To systematically assess the beneficial and harmful effects of the biologic treatment on HRQoL outcomes in people with Crohn’s disease.
This is a protocol.
The impact of biological interventions on health-related quality of life in adults with Crohn's disease
You may also be interested in:
- Biologic drugs for induction and maintenance of remission in Crohn's disease: a network meta-analysis
- Antibiotics for the treatment of Crohn's disease
- A comparison of endoscopic and surgical treatment of strictures in patients with Crohn’s disease
- Adalimumab for maintenance of remission in Crohn's disease
- Endoscopic scoring indices for evaluation of disease activity in Crohn's disease